bee32
bee32 / iStockphoto.com
13 March 2018Americas

Allergan and tribe claim PTAB can’t decide on Restasis patents

Allergan and the Saint Regis Mohawk Tribe have argued that the Patent Trial and Appeal Board (PTAB) doesn’t have the jurisdiction to decide on the validity of patents concerning a dry-eye treatment while its recent decision is being appealed.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
2 March 2018   The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.
Americas
26 February 2018   The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.
Americas
21 January 2021   The US Court of Appeals for the Federal Circuit has affirmed a decision by the US Patent Trial and Appeal Board which centered on the validity of a patent for an ophthalmic illuminator.

More on this story

Americas
2 March 2018   The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.
Americas
26 February 2018   The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.
Americas
21 January 2021   The US Court of Appeals for the Federal Circuit has affirmed a decision by the US Patent Trial and Appeal Board which centered on the validity of a patent for an ophthalmic illuminator.

More on this story

Americas
2 March 2018   The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.
Americas
26 February 2018   The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.
Americas
21 January 2021   The US Court of Appeals for the Federal Circuit has affirmed a decision by the US Patent Trial and Appeal Board which centered on the validity of a patent for an ophthalmic illuminator.